Liraglutide significantly reduced the monocyte adhesion, the expression of adhesion molecules, MAPK/NF-kB activation, peroxynitrite levels, and endothelial microvesicle release in the HUVECs exposed to tumor necrosis factor-alpha (obtained from patients with GDM) [185]. This evidence concerns the gene TNF and gestational diabetes.